Systems and methods for designing randomized controlled studies
AssigneeOwkin, Inc.
InventorsFélix Balazard, Raphaëlle Momal, Paul Trichelair, Michael Blum
Life of this patent
Estimating the term…
Abstract
Methods for designing a study, e.g., randomized controlled trial (RCT), and methods for evaluating sample size in an uncommenced or ongoing study are provided. Also provided are methods for conducting co-variate adjustment using covariates (e.g., prognostic covariates) obtained by deep learning models in a study.
Claims39
A method for designing a randomized controlled trial (RCT) with a time-to-event outcome, said method comprising:
- selecting a covariate for adjustment;
- and
- calculating a number of events required to obtain a statistical power based on a formula:
- Nadjusted=Noriginal(1−RCS2);
- wherein
- the RCT is conducted using the calculated number of events,
- wherein the Noriginal is an original number of events required to obtain the statistical power without covariate adjustment,
- wherein the Nadjusted is an adjusted number of events required to obtain the statistical power with covariate adjustment, and
- wherein the RCS2 is computed on data external to the RCT based on a formula:
- R
- CS
- 2
- =
- 1
- -
- exp
- [
- -
- 2
- n
-
- (
- l
- 1
- -
- l
- 0
- )
- ]
- ,
- wherein
- the RCS2 is a Cox-Snell R2,
- the n is a number of participants,
- the l0 is a log-likelihood of a Cox model to explain the time-to-event outcome with an intercept only, and
- the l1 is a log-likelihood of a Cox model to explain the time-to-event outcome with an intercept and with covariate adjustment.
A method for evaluating sample size at an interim stage of an ongoing randomized controlled trial (RCT), said method comprising:
- selecting a covariate for adjustment;
- obtaining blinded RCT data;
- and
- performing a blinded sample size reestimation, at the interim stage, using RCS2 and a formula:
- Nadjusted=Noriginal(1−RCS2);
- wherein
- the RCT is further conducted using the blinded sample size reestimation,
- wherein the Noriginal is an original number of events required to obtain the statistical power without covariate adjustment,
- wherein the Nadjusted is a reestimated number of events required to obtain the statistical power;
- wherein the RCS2 is computed, at the interim stage, on the blinded RCT data based on a formula:
- R
- CS
- 2
- =
- 1
- -
- exp
- [
- -
- 2
- n
-
- (
- l
- 1
- -
- l
- 0
- )
- ]
- ,
- wherein
- the RCS2 is a Cox-Snell R2,
- the n is a number of participants,
- the l0 is a log-likelihood of a Cox model to explain the time-to-event outcome with an intercept only, and
- the l1 is a log-likelihood of a Cox model to explain the time-to-event outcome with an intercept and with covariate adjustment.
The method of any one of 10-15, wherein the disease is cancer.
A machine readable medium having executable instructions to cause one or more processing units to perform a method of designing a randomized controlled trial (RCT), the method comprising:
- selecting a covariate for adjustment;
- and
- calculating a sample size required to obtain a statistical power based on a formula:
- Nadjusted=Noriginal (1−RCS2);
- wherein
- the RCT is conducted using the calculated sample size,
- wherein the Noriginal is an original number of events required to obtain the statistical power without covariate adjustment,
- wherein the Nadjusted is an adjusted number of events required to obtain the statistical power with covariate adjustment, and
- wherein the RCS2 is computed on data external to the RCT based on a formula:
- R
- CS
- 2
- =
- 1
- -
- exp
- [
- -
- 2
- n
-
- (
- l
- 1
- -
- l
- 0
- )
- ]
- ,
- wherein
- the RCS2 is a Cox-Snell R2,
- the n is a number of participants,
- the l0 is a log-likelihood of a Cox model to explain the time-to-event outcome with an intercept only, and
- the l1 is a log-likelihood of a Cox model to explain the time-to-event outcome with an intercept and with covariate adjustment.
A machine readable medium having executable instructions to cause one or more processing units to perform a method of evaluating sample size required to obtain a statistical power at an interim stage of an ongoing randomized controlled trial (RCT), the method comprising:
- selecting a covariate for adjustment;
- obtaining blinded RCT data;
- and
- performing a blinded sample size reestimation, at the interim stage, using RCS2 and a formula:
- Nadjusted=Noriginal(1−RCS2);
- wherein
- the RCT is further conducted using the blinded sample size reestimation,
- wherein the Noriginal is an original number of events required to obtain the statistical power without covariate adjustment,
- wherein the Nadjusted is a reestimated number of events required to obtain the statistical power;
- wherein the RCS2 is computed, at the interim stage, on the blinded RCT data based on a formula:
- R
- CS
- 2
- =
- 1
- -
- exp
- [
- -
- 2
- n
-
- (
- l
- 1
- -
- l
- 0
- )
- ]
- ,
- wherein
- the RCS2 is a Cox-Snell R2,
- the n is a number of participants,
- the l0 is a log-likelihood of a Cox model to explain the time-to-event outcome with an intercept only, and
- the l1 is a log-likelihood of a Cox model to explain the time-to-event outcome with an intercept and with covariate adjustment.
Dependencies are inferred from the claim text.